News
Microthrombi, necrosis seen in COVID-19 hearts on autopsy
February 3, 2021
A new autopsy series shows microthrombi and focal necrosis in hearts of patients who died of COVID-19. The findings support use of anticoagulation, but best dosing remains unclear, researchers say.
News
DAPT increases bleeding without decreasing mortality in patients with coronary disease and diabetes
February 2, 2021
In patients who have diabetes with known coronary disease but without prior MI or stroke, what is the effect of dual-antiplatelet therapy (DAPT) with aspirin and ticagrelor on cardiovascular outcomes and bleeding events?
News
Newer iPhones disable implanted defibrillators
February 1, 2021
Some newer smartphones are equipped with magnets sufficiently powerful to disable an implanted cardiac defibrillator.
News
Neprilysin, corin singled out for potential to guide heart failure therapy
January 28, 2021
Circulating neprilysin and corin concentrations, which correlate with outcomes, could possibly be assessed to guide heart failure therapy.
News
Myocarditis by CMR may be rare after COVID-19 in elite athletes
January 27, 2021
Some supposed ‘myocarditis’ detected by MRI after COVID-19 in university varsity competitors might be normal heart muscle – normal for athletes, that is, propose researchers.
News
Full-dose anticoagulation reduces need for life support in COVID-19
January 25, 2021
“We have treatments that are improving outcomes but not as many that reduce mortality, so we’re hopeful when the full dataset comes in that will be confirmed.”
News
Think twice before intensifying BP regimen in older hospitalized patients
January 20, 2021
Does intensifying antihypertensive regimens in older patients hospitalized for noncardiac conditions lead to better long-term blood pressure control or does this practice potentially cause harm?
News
Biomarker HF risk score envisioned as SGLT2 inhibitor lodestar in diabetes
January 19, 2021
Together, four “easily measured” biomarkers predicted 5-year heart failure risk in patients with diabetes or prediabetes, potentially identifying best candidates for SGLT2 inhibitor therapy, some say.
News
CVD deaths rose, imaging declined during pandemic
January 14, 2021
Two new papers quantify the impact of COVID-19 on patients with heart disease: more deaths, less disease testing or diagnosis. Experts suggest shutdowns may have been too complete.
News
A standardized approach to postop management of DOACs in AFib
January 13, 2021
Is it safe to adopt a standardized approach to direct oral anticoagulant (DOAC) interruption for patients with atrial fibrillation (AFib) who are undergoing elective surgeries/procedures?